Yankees Score with ...
Health Care: Drugs
SciClone Pharmaceuticals (SCLN: NASDAQ)
$4.86 -0.11 | -2.21%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 4.86 |
| 52 Week High | 7.58 |
| 52 Week Low | 3.68 |
| Avg. Daily Vol. (Mil) | 0.25 |
| Beta (3 year) | 2.17 |
| Share Related Items | |
| Mkt Cap (Mil) | 262.82 |
| Shares Out (Mil) | 54.08 |
| Float (Mil) | 53.64 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.00 |
| Current Ratio | 4.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.01 |
| Valuation Ratios | |
| Price Earnings | 30.40 |
| Price/Sales | 1.68 |
| Price/Book | 1.84 |
| Price/Cash Flow | 20.10 |
| Per Share Data | |
| Earnings | 0.16 |
| Sales | 2.89 |
| Book Value | 2.64 |
| Cash Flow | 0.24 |
| Business Summary | |
|---|---|
| SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular among others. | |
| General Information | |
| 950 Tower Lane
Suite 900 Foster City, CA 94404 |
|
| www.sciclone.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 870 | |
| CEO: Dr. Friedhelm Blobel,PhD | |
| Short Interest | |
| Current Month (Mil) | 3.29 |
| Previous Month (Mil) | 3.20 |
| Short Interest Ratio (Days) | 11.50 |
| Management Effectiveness | |
| Return on Equity | 6.70 |
| Return on Assets | 5.50 |
| Return on Investments | 6.70 |
| Profitability | |
| Gross Margin | 86.40 |
| EBIT Margin | 4.10 |
| Profit Margin | 6.20 |
Portfolios with SCLN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorTop-Rated Biotechnology Stocks
- UserDivFive
- Contributor10 Pharma Stocks With 100% ...
- UserPicking Winners
- UserMicroCap Biotech/Pharma Sto...
- Userbiotech
- UserDaktowilly Portfolio 1
Latest SCLN Headlines from TheStreet
- Healthcare Sector: High Quality Stocks At A Great Value 03.18.13 | 02:03 pm
- 4 Stocks Under $10 Moving Higher 02.26.13 | 02:02 pm
- Stocks Under $5: Discount Drug Name
11.29.12 | 06:11 am - 9 Stocks On Winning Streaks With Significant Hedge Fund Buying 10.16.12 | 04:10 pm
- 3 Stocks Under $10 Making Big Moves 09.18.12 | 02:09 pm
- 3 Biotech Stocks Under $10 Surging Higher 08.09.12 | 01:08 pm
- SciClone Rises On Unusually High Volume (SCLN) 06.22.12 | 04:06 pm
- SciClone Stock Hits New 52-Week High (SCLN) 06.11.12 | 12:06 pm
- SciClone Stock Gaps Up On Today's Open (SCLN) 03.14.12 | 09:03 am
- SciClone Reaches New 52-Week High (SCLN) 07.14.11 | 10:07 am
Press Releases for SCLN
- Kahn Swick & Foti, LLC Announce Continuing Investigation Into SciClone Pharmaceuticals, Inc. – Firm Appointed Co-lead Counsel In Securities Class Action – SCLN - Business Wire 11.02.10 | 06:11 pm
- Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against SciClone Pharmaceuticals, Inc. - Business Wire 09.23.10 | 10:09 am
- Ryan & Maniskas, LLP Announces Class Action Lawsuit Against SciClone Pharmaceuticals, Inc. - Business Wire 08.20.10 | 07:08 pm
- Kendall Law Group Investigates SciClone Pharmaceuticals, Inc. For Shareholders - Business Wire 08.20.10 | 01:08 pm
- Robbins Umeda LLP Announces Investigation Of SciClone Pharmaceuticals, Inc. - Business Wire 08.12.10 | 07:08 pm
- Finkelstein Thompson LLP Announces Investigation Of SciClone Pharmaceuticals, Inc. - Business Wire 08.11.10 | 04:08 pm
- Goldfarb Branham LLP Investigating SciClone Pharmaceuticals For Investors - Business Wire 08.11.10 | 12:08 pm
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of SciClone Pharmaceuticals, Inc. - Business Wire 08.10.10 | 08:08 pm
- Levi & Korsinsky, LLP Investigates SciClone Pharmaceuticals, Inc. - Business Wire 08.10.10 | 08:08 pm
- Roy Jacobs & Associates Investigating SciClone Pharmaceuticals, Inc. For Possible Securities Law Violations ("SCLN") - Business Wire 08.10.10 | 05:08 pm
Partner Headlines for SCLN
- SciClone Pharmaceuticals Earnings: Here’s Why Shares are Down Now - Wall St. Cheat Sheet 04.01.13 | 06:04 am
- SciClone Pharmaceuticals Earnings: Here’s Why Shares are Down Now - Wall St. Cheat Sheet 04.01.13 | 06:04 am
- Weekly CFO Sells Highlight: V, SCLN, VR, AMSG - GuruFocus 06.25.12 | 03:06 pm
- 2 $4 Stocks With Rapid Sales Growth That Are Heading Higher - Seeking Alpha 01.31.12 | 06:01 am
- Vertex A Steal Based On Blockbuster Hepatitis C Drug Sales - Seeking Alpha 10.28.11 | 06:10 am
- 9 Stocks Trading Under $7 With Monster Upside Potential - Seeking Alpha 06.09.11 | 08:06 am
- SciClone: Novamed Acquisition Helps, But Questions Remain - Seeking Alpha 05.20.11 | 07:05 am
- 19 High Growth Micro Cap Stocks Under $10 - Seeking Alpha 01.23.11 | 07:01 am
- UPDATE 1-SciClone Pharma Q3 EPS beats, raises FY profit view - Reuters 11.08.10 | 05:11 pm
- Healthcare Headlines: Santarus Rallies, Amgen Announces Results - Seeking Alpha 10.06.10 | 08:10 am
